PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · USD

$1.52

+0.22 (+16.9%)· Recorded snapshot

Market cap	110.2M
Net income (ttm)	-33.7M
EPS (ttm)	-$0.64
Shares out	72.5M
Volume	14,637,624
Beta	1.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -33.7M
EPS (ttm): -$0.64
Market cap: 110.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-544

P25 -113.8P50 -46.5P75 -0.9

ROIC-98.6

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All PDSB indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001472091
Company name	PDS Biotechnology Corporation
Country	United States
Country code	US
CUSIP number	70465T107
Earnings date	2026-11-12
Earnings time	bmo
Employees	21
Employees change	-3
Employees growth	-12.5%
Enterprise value	$108.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US70465T1079
Last 10-K release date	2026-03-30
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2019-03-18
Last stock split type	Reverse
Market cap	$110.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$1.52
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PDSB
U.S. state	New Jersey
Website	https://www.pdsbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-42.11%
FCF / EV yield	-18.05%
FCF yield	-17.81%
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.6M
ROA	-70.59%
ROA (5Y)	-39.64%
ROCE	779.57%
ROE	-543.97%
ROE (5Y)	-129.39%
ROIC	-98.61%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	11
EPS growth years	3
Net income growth years	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$60,518
EBIT	$-27.8M
EBITDA	$-27.8M
EPS	$-0.64
FCF per share	$-0.23
Financing cash flow	$-9.5M
Free cash flow	$-16.8M
Free cash flow minus SBC	$-21.5M
Net borrowing	$-19.9M
Net cash flow	$-26.3M
Net income	$-33.7M
Operating cash flow minus SBC	$-21.5M
Operating income	$-27.8M
Stock-based compensation	$4.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-0.06
Interest coverage	-4.18
Long-term assets	$1.8M
Long-term liabilities	$9,476
Net cash (debt)	$1.2M
Net cash / market cap	1.31%
Net cash growth	-90.76%
Piotroski F-Score	1
Property, plant and equipment	$213,440
Shareholders' equity	$-3.6M
Tangible book value	$-3.6M
Tangible book value per share	$-0.06
Total assets	$8.8M
Total cash	$5.6M
Total debt	$4.4M
Total liabilities	$12.4M
WACC	15.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$7M
Current liabilities	$12.4M
Current ratio	0.57
Net working capital	$-6.6M
Quick ratio	0.45
Working capital	$-5.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-30.89%
Dividend yield	0%
Shareholder yield	-30.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.85
1D price change	16.92%
1M price change	90.69%
1M total return	90.69%
1W price change	22.58%
1W total return	22.58%
1Y price change	62.79%
1Y return CAGR	62.85%
1Y total return	62.79%
20-day SMA	$1.17
200-day SMA	$0.82
3M price change	119.43%
3M total return	119.43%
3Y price change	-62.19%
3Y return CAGR	-27.68%
3Y total return	-62.19%
50-day SMA	$0.75
50-day SMA vs 200-day SMA	50under200
52-week high	$1.79
52-week high date	2026-10-13
52-week low	$0.20
52-week low date	2026-08-19
5Y price change	-86.96%
5Y return CAGR	-33.47%
5Y total return	-86.96%
6M price change	63.44%
6M total return	63.44%
All-time high	$17.85
All-time high date	2021-09-24
All-time low	$0.20
All-time low date	2026-08-19
Average true range (ATR)	$0.20
Average volume	12.6M
Beta (1Y)	4.56
Beta (2Y)	3
Beta (5Y)	1.17
Change from 52-week high	-15.08%
Change from 52-week low	678.69%
Change from all-time high	-91.48%
Change from all-time low	678.69%
Change from open	16.92%
Day's gap	0%
Dollar volume	$22.2M
High price	$1.61
Low price	$1.30
Monthly RSI	48.89
Open price	$1.30
Position in 52-week range	72.58%
Premarket change	0.77%
Premarket close	$1.30
Premarket price	$1.31
Premarket volume	333.2K
Previous close	$1.30
Price vs 150-day SMA	78.3%
Price vs 20-day SMA	29.91%
Price vs 200-day SMA	84.4%
Price vs 50-day SMA	102.96%
Relative volume	1.18
RSI	63.71
Sharpe ratio	1.14
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	0.14
Sortino ratio	2.08
Sortino ratio (3Y)	0.56
Sortino ratio (5Y)	0.28
Volume	14.6M
Weekly RSI	64.68
YTD price change	97.45%
YTD total return	97.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.1M
Float percentage	80.11%
Shares change (QoQ)	0.29%
Shares change (YoY)	30.89%
Shares held by insiders	1.95%
Shares held by institutions	10.97%
Shares outstanding	72.5M
Short % of float	5.83%
Short % of shares	4.67%
Short ratio	0.1 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	201

Deeper analysis on PDSB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PDSB report

Is a complete PDSB research report available?

No complete published report is available for PDS Biotechnology Corporation (PDSB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PDS Biotechnology Corporation (PDSB)

Price

Financial snapshot

Fair-value bridge

Latest news · PDSB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PDSB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on PDSB

Frequently asked questions